The post Bitget Launches Video Campaign With World Cup Champion Julián Álvarez appeared on BitcoinEthereumNews.com. Bitget launches a global campaign with LALIGAThe post Bitget Launches Video Campaign With World Cup Champion Julián Álvarez appeared on BitcoinEthereumNews.com. Bitget launches a global campaign with LALIGA

Bitget Launches Video Campaign With World Cup Champion Julián Álvarez

  • Bitget launches a global campaign with LALIGA star Julián Álvarez.
  • The video shows seamless multi-asset trading on one platform.
  • The campaign highlights Bitget’s Universal Exchange vision.

Leading Universal exchange Bitget has launched a new global video campaign with World Cup winner Julián Álvarez. Using football culture, the campaign conveys that traders shouldn’t need multiple platforms to access global markets.

Set in a football megastore, the video turns trading into an easy visual idea. Through this campaign the idea of Bitget is clear and conveyed in an intuitive way. Crypto takes the place of footballs, stocks show up as shin guards, and forex is laced into boots built for speed. The video with Julián Álvarez explains how Bitget is standing as a single hub helping traders with forex, stock and crypto.

Bringing the Universal Exchange Vision to Life

Since Bitget’s launch in 2018, the platform has emerged into a Universal Exchange, giving users access to crypto, tokenized stocks, gold, forex, and derivatives through a single account. The campaign highlights the use cases of the platform on how it helps traders to shift capital with ease across different assets.

This reflects how today’s markets work — they’re connected, fast-moving, and open 24/7.

“Just as a professional footballer needs access to the best equipment in one place, Bitget gives traders seamless access to diverse asset classes within one platform,” said Ignacio Aguirre, Chief Marketing Officer at Bitget. “That convenience is a competitive edge.”

The message reinforces Bitget’s position as a fast, all-in-one platform that gives traders greater control in volatile global markets.

Why Julián Álvarez Fits the UEX Narrative

Álvarez’s role in the campaign reflects the values behind Bitget’s UEX model: consistency, readiness, and adaptability. As markets change and opportunities appear across different asset classes, Bitget is built to provide continuous access without interruption.

Now live across Bitget’s global channels, the video is another step in the company’s strategy to combine culture, sport, and trading education. As Bitget expands its multi-asset offerings, the message stays clear: trade smarter, stay ready, and keep everything in one place.

Bitget is the world’s largest Universal Exchange (UEX), serving over 125 million users worldwide. It offers access to more than 2 million crypto tokens, along with tokenized stocks, ETFs, commodities, forex, and precious metals like gold.

Bitget helps users trade smarter with an AI-powered trading agent that supports execution and decision-making. The company is also driving crypto adoption through global partnerships with LALIGA and MotoGP™, as well as through its collaboration with UNICEF to bring blockchain education to 1.1 million people by 2027.

Today, Bitget leads the tokenized traditional finance market, offering the lowest fees and deep liquidity across more than 150 regions globally.

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/bitget-launches-video-campaign-with-world-cup-champion-julian-alvarez/

Market Opportunity
Starpower Logo
Starpower Price(STAR)
$0.08901
$0.08901$0.08901
-0.63%
USD
Starpower (STAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26